title: Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer.
authors.affiliation: Dept. of Medical Oncology, Rotterdam Cancer Institute Daniel den Hoed Kliniek, The Netherlands.
authors.forename: C J
authors.initials: CJ
authors.lastname: Rodenburg
authors.forename: K
authors.initials: K
authors.lastname: Nooter
authors.forename: H
authors.initials: H
authors.lastname: Herweijer
authors.forename: C
authors.initials: C
authors.lastname: Seynaeve
authors.forename: R
authors.initials: R
authors.lastname: Oosterom
authors.forename: G
authors.initials: G
authors.lastname: Stoter
authors.forename: J
authors.initials: J
authors.lastname: Verweij
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003524:Cyclosporins / Q000008:administration & dosage; D004341:Drug Evaluation; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D003524:Cyclosporins; D014747:Vinblastine